References
- Reynolds T B.: What to do about oesbphageal varices ? N Engl J Med. 1983; 309: 1575–6.
- Bloom A L.: Intravascular coagulation and the liver. Brit J Haematol. 1975; 57: 290–7.
- Verstracte M, Vermylen J, Collen D.: Intravascular coagulation in liver disease. Ann Rev Med. 1974; 25: 447–55.
- Soehendra N, de Heer K, Kcmpeneers I, Runge M.: Sclerotherapy of oesophageal varices: acute arrest of gastrointestinal hemorrhage or longterm therapy ? Endoscopy. 1983; 15: 136–40.
- Boyer C, Rothschild C, Wolf M, Amiral J, Meyer D, Larrieu M J.: A new method for the estimation of protein C by clisa. Thromb Res. 1984; 36: 579–89.
- Friberger, P, Knos M, Gustavsson S, Aurell L, Claeson G: Methods for determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis. 1978; 7: 138–45.
- Teger-Nilsson A C, Friberger P, Gyzander E. Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. Scand J Clin Lhb Invest. 1977; 37: 402–9.
- Abildgaard U, Lie M, Odegaard O R. Antithrombin (heparin cofactor) assay with « new » chromogenic substrates (S-2238 and chromozym-TH). Thromb Res. 1977; 11: 549–53.
- Odegaard O R, Lie M, Abildgaard U. Heparin cofactor activity measured with an amidolytic method. Thromb Res. 1975; 6: 287–94.
- Merskey C, Lalezari, P, Johnson A J. A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum. Proc Soc Exp Biol (NY). 1969; 131: 871–5.
- Holvoet P, Cleemput H, Collen D. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA. Thromb Haemostas. 1985; 54: 684–7.
- Colman, R W, Robbay S J, Minna J D. Disseminated intravascular coagulation: a reappraisal. Ann Rev Med. 1979; 30: 359–74.
- Spero J A, Lewis J H, Hasiba U. Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemostas (Stuttg). 1980;43:28–33.
- Baele G, Matthys E, Barbier F. Antihaemophilic factor A activity, F VIII-related antigen and von Willebrand factor in hepatic cirrhosis. Acta Haemat. 1977; 57: 290–7.
- Green A J, Ratnoff, O D. Elevated antihaemophilic factor (AHF, factor VIII) procoagulant activity and AHF-like antigen in alcoholic cirrhosis of the liver. J Lab Clin Med. 1974; 83: 189–97.
- Hallen A, Nilsson I M. Coagulation studies in liver disease. Thromb Diath Haemorrh (Stuttg). 1969; 11: 51–63.
- Mannucci P M, Vigano S. Deficiencies of protein C, an inhibitor of blood coagulation. Lancet. 1982; 2: 463–7.
- Griffin J H, Mosher D F, Zimmerman T S, Kleiss A J. Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation. Blood. 1982; 60: 261–4.
- Gardner E C, Brooks W S. Absence of disseminated intravascular coagulation with endoscopic sclerosis of (Esophageal varices. Gastrointest Endosc. 1982; 28: 67–9.